✦ LIBER ✦

Gaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients

✍ Scribed by Neal J. Weinreb; Mario C. Aggio; Hans C. Andersson; Generoso Andria; Joel Charrow; Joe T.R. Clarke; Anders Erikson; Pilar Giraldo; Jack Goldblatt; Carla Hollak; Hiroyuki Ida; Paige Kaplan; Edwin H. Kolodny; Pramod Mistry; Gregory M. Pastores; Ricardo Pires; Ainu Prakesh-Cheng; Barry E. Rosenbloom; C. Ronald Scott; Elisa Sobreira; Anna Tylki-Szymańska; Ashok Vellodi; Stephan vom Dahl; Rebecca S. Wappner; Ari Zimran

Book ID: 117821830
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 116 KB
Volume: 41
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2004.07.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recommendations on Diagnosis, Treatment,

Recommendations on Diagnosis, Treatment, and Monitoring for Gaucher Disease

✍ Ana Maria Martins; Eugenia Ribeiro Valadares; Gilda Porta; Janice Coelho; José S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Enzyme replacement therapy and monitorin

Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations

✍ Joel Charrow; Hans C. Andersson; Paige Kaplan; Edwin H. Kolodny; Pramod Mistry; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 162 KB

7-year safety and efficacy with velagluc

7-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease

✍ Elstein, Deborah; Crombez, Eric; Zahrieh, David; Wang, Nan; Zimran, Ari 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Guidance on the use of miglustat for tre

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease

✍ Neal J. Weinreb; John A. Barranger; Joel Charrow; Gregory A. Grabowski; Henry J. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Validation study of a DS3 severity score

Validation study of a DS3 severity score index for adult patients with type 1 Gaucher disease (GD1)

✍ Weinreb, Neal J.; Finegold, David; Feingold, Eleanor; Rosenbloom, Barry; Shankar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Type 1 Gaucher disease: null and hypomor

Type 1 Gaucher disease: null and hypomorphic novel chitotriosidase mutations—implications for diagnosis and therapeutic monitoring

✍ Marie E. Grace; Manisha Balwani; Irina Nazarenko; Ainu Prakash-Cheng; Robert J. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Human plasma chitotriosidase (Chito) is a useful diagnostic and therapeutic biomarker for Type 1 Gaucher disease (GD). However, approximately 40% of Caucasians are heterozygous or homozygous for a common null mutation, c.1049\_1072dup24 (dup24) in the chitotriosidase gene (chitinase 1, CHIT1), that